A Comparative study of efficacy and safety of Tapcom combination ophthalmic solution and Xalacom combination eye drops.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Sep 2017
At a glance
- Drugs Tafluprost/timolol (Primary) ; Latanoprost/timolol
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Santen Pharmaceutical
- 04 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 20 Sep 2016 New trial record